Used in pharmaceutical synthesis as a chiral intermediate for developing bioactive molecules, particularly in the production of central nervous system agents. Its structural features support binding to neurological targets, making it valuable in the research of antidepressants and antipsychotic drugs. The compound's stereochemistry enhances selectivity in receptor interactions, improving efficacy and reducing side effects in drug candidates. It is also employed in structure-activity relationship (SAR) studies to optimize potency and pharmacokinetic properties of new therapeutic compounds.